These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8377382)
21. The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Bover J; Jara A; Trinidad P; Rodriguez M; Martin-Malo A; Felsenfeld AJ Kidney Int; 1994 Aug; 46(2):310-7. PubMed ID: 7967341 [TBL] [Abstract][Full Text] [Related]
22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
23. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy. Rodriguez M; Felsenfeld AJ; Llach F Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307 [TBL] [Abstract][Full Text] [Related]
24. Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen. Ori Y; Korzets A; Malachi T; Gafter U; Breitbart H J Lab Clin Med; 1999 Apr; 133(4):391-400. PubMed ID: 10218771 [TBL] [Abstract][Full Text] [Related]
25. Insulin release from pancreatic islets: effects of CRF and excess PTH. Fadda GZ; Akmal M; Premdas FH; Lipson LG; Massry SG Kidney Int; 1988 Jun; 33(6):1066-72. PubMed ID: 3043075 [TBL] [Abstract][Full Text] [Related]
26. Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure. Michaud J; Naud J; Chouinard J; Désy F; Leblond FA; Desbiens K; Bonnardeaux A; Pichette V J Am Soc Nephrol; 2006 Nov; 17(11):3041-8. PubMed ID: 17021269 [TBL] [Abstract][Full Text] [Related]
27. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306 [TBL] [Abstract][Full Text] [Related]
28. Impaired in vivo antibody production in CRF rats: role of secondary hyperparathyroidism. Gaciong Z; Alexiewicz JM; Massry SG Kidney Int; 1991 Nov; 40(5):862-7. PubMed ID: 1762290 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289 [TBL] [Abstract][Full Text] [Related]
30. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism. Togashi K; Takahashi N; Ando K; Tsukamoto Y; Marumo F Int J Artif Organs; 1990 Feb; 13(2):77-82. PubMed ID: 2347659 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of down-regulation of the renal parathyroid hormone receptor in rats with chronic renal failure. Josifovska T; Nonoguchi H; Machida K; Tomita K Nephron Exp Nephrol; 2003; 93(4):e141-9. PubMed ID: 12759575 [TBL] [Abstract][Full Text] [Related]
32. In vitro effect of PTH on normal T cell functions. Shasha SM; Kristal B; Barzilai M; Makov UE; Shkolnik T Nephron; 1988; 50(3):212-6. PubMed ID: 2976121 [TBL] [Abstract][Full Text] [Related]
33. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease. Kaneko T; Osono E; Hayama N; Lino Y; Terashi A Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093 [TBL] [Abstract][Full Text] [Related]
34. Verapamil reverses PTH- or CRF-induced abnormal fatty acid oxidation in muscle. Perna AF; Smogorzewski M; Massry SG Kidney Int; 1988 Dec; 34(6):774-8. PubMed ID: 3210537 [TBL] [Abstract][Full Text] [Related]
35. Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure. Smogorzewski M; Koureta P; Fadda GZ; Perna AF; Massry SG J Am Soc Nephrol; 1991 Apr; 1(10):1162-8. PubMed ID: 1768811 [TBL] [Abstract][Full Text] [Related]
36. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. Klin M; Smogorzewski M; Ni Z; Zhang G; Massry SG J Clin Invest; 1996 May; 97(10):2167-73. PubMed ID: 8636395 [TBL] [Abstract][Full Text] [Related]
37. A novel mechanism for skeletal resistance in uremia. Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099 [TBL] [Abstract][Full Text] [Related]
38. Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats. Naud J; Harding J; Lamarche C; Beauchemin S; Leblond FA; Pichette V Drug Metab Dispos; 2016 Aug; 44(8):1174-9. PubMed ID: 27271372 [TBL] [Abstract][Full Text] [Related]
39. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823 [TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone interferes with extrarenal disposition of potassium in chronic renal failure. Soliman AR; Akmal M; Massry SG Nephron; 1989; 52(3):262-7. PubMed ID: 2739866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]